Market Tracker

04/22 4:45pm ET

Rosetta Genomics Ltd (NASDAQ:ROSG)

4.05
Data as of Apr 22
 +0.01 / +0.25%
Today’s Change
2.35
Today|||52-Week Range
6.69
+38.70%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close4.04
Today’s open4.03
Day’s range3.90 - 4.30
Volume310,246
Average volume (3 months)490,580
Market cap$44.5M
Dividend yield--
Data as of 4:00pm ET, 04/22/2014

Growth & Valuation

Earnings growth (last year)+96.62%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+95.15%
P/E ratio--
Price/Sales102.47
Price/Book1.25

Competitors

 Today’s
change
Today’s
% change
IMCLImmunoClin Corp-0.15-3.41%
CANFCan Fite Biopharma L...+0.03+0.55%
RXIIRXi Pharmaceuticals ...+0.29+7.84%
CRMDCorMedix Inc+0.04+2.16%
Data as of 4:07pm ET, 04/22/2014

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$201.0K
Annual profit (last year)-$10.5M
Net profit margin-5,321.39%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Head-Investor Relations
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, --

Forecasts